Solvay Stock: Surge of Over 4% Driven by Annual Results and Strong Free Cash Flow
Solvay's stock saw significant gains on Tuesday, February 24, following the release of its 2025 annual results. The Belgian chemical company's share price reached 28.04 euros, up by 4.39% from the previous day. This session occurred amidst a dual focus for the group, balancing financial performance and industrial adjustment.
Annual Financial Performance and Industrial Adjustments
On Tuesday, Solvay disclosed its financial statements for the fiscal year 2025, revealing a robust free cash flow generation despite a challenging market environment. The group maintained a solid EBITDA margin, even as persistent weak demand and geopolitical tensions weighed on the European chemical sector. Additionally, on the eve of this announcement, Solvay declared a reduction in soda ash production capacity at its Spanish site in Torrelavega. This decision addresses the global oversupply in the market, combined with high energy costs across the continent. This industrial adjustment reflects the group's intent to streamline its production tools to safeguard profitability in an extended low cycle. The next key date in the financial calendar is the release of the first-quarter 2026 results, scheduled for May 7.
Technical Analysis and Market Position
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Technically, the stock has crossed its 200-day moving average, located at 27.82 euros, a signal often interpreted as a return to a medium-term bullish trend. The current price of 28.04 euros is approaching the resistance level identified at 28.50 euros, a breach of which could signal a new phase of appreciation. The Relative Strength Index (RSI) at 66 indicates that the stock is in a zone of positive momentum without reaching the overbought threshold typically set at 70. On the analyst front, KBC Securities updated its recommendation on Solvay on Tuesday, issuing a 'hold' rating. Over the past year, the stock has declined by 10.81%, while its three-month performance is nearly stable at +1.01%. Today's rebound brings the weekly gain to +0.72%, positioning the share price above its 20 and 50-day moving averages, both located at 26.76 euros.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.